Laura E. Niklason - 15 Sep 2022 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
President, CEO and Director, Director, 10%+ Owner
Signature
/s/ Laura E. Niklason by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
15 Sep 2022
Net transactions value
-$6,090,000
Form type
4
Filing time
19 Sep 2022, 16:36:28 UTC
Previous filing
13 Jun 2022
Next filing
12 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Sale $6,090,000 -1,522,500 -7.4% $4.00 18,930,004 15 Sep 2022 By Ayabudge LLC F1
holding HUMA Common Stock 1,158,240 15 Sep 2022 Direct
holding HUMA Common Stock 510,161 15 Sep 2022 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made by an entity controlled by the spouse of Laura Niklason, the Reporting Person. This sale was done as a block trade to an existing investor of Humacyte, Inc. Laura Niklason is treated as indirectly beneficially owning the shares sold, resulting in the requirement to file this Form 4. However, no shares directly owned by Laura Niklason were sold in this transaction.